The global Bioactive Wound Management market size was valued USD 1.8 billion in 2021 and is expected to rise to USD 2.9 billion by 2028 at a CAGR of 7.9 %.
With a compound annual growth rate (CAGR) of around 7.9 percent during the projected period, the global bioactive wound management market size is predicted to increase in value from USD 1.8 billion in 2021 to USD 2.9 billion by 2028. The drivers, restraints/challenges, and their effects on demand throughout the projected period are examined in the study for the bioactive wound management market. The research also investigates new potential in the bioactive wound management market.
A variety of wound dressings are available on the bioactive wound care market. The wound dressings in this business are renowned for their microbial infection-fighting capabilities and biodegradable qualities. Additionally, these wound dressings include an antibiotic component that promotes healing and prevents infections. The traditional wound-healing products are being replaced with bioactive wound care items. When compared to bioactive wound care treatments, the older, more conventional wound healing therapies are less successful. The bioactive wound care solutions are both cost-effective and speed up wound healing.
Global medical care delivery has transformed as a result of the COVID-19 pandemic. Numerous hospitals and departments have had their patient profiles for COVID-19 patients revised as a result of the increased demand brought on by the rising incidence of COVID-19 hospitalizations. As a result, a large number of elective procedures were postponed or canceled globally in order to reserve or refocus the limited capacities and resources toward COVID-19 patient care. Additionally, there are reports of several other kinds of skin injuries among healthcare workers doing COVID-19 service tasks while wearing PPE kits. Doctors and nurses employ bioactive wound care solutions to treat such wounds while wearing grade 2 and 3 PPE kits. The market for bioactive wound care products is anticipated to develop during the COVID-19 outbreak during the forecast period as a result of such instances occurring all over the world.
Growing demand for antimicrobial dressings to foster the market growth
Antimicrobial dressings are those used to treat wounds that contain an antiseptic substance to help kill any bacteria that may be present. These dressings are mostly used on wounds that are at a greater chance of infection as well as wounds that are failing to heal as a result of an increase in bacterial load. The increased desire to decrease hospital-acquired infections and the presence of germs that are antibiotic-resistant are further factors contributing to the increase in demand for these dressings which in turn is driving the growth of the global bioactive wound management market. Further, the market is driven by the rise in the frequency of chronic injuries and the number of surgical operations. Additionally, a spike in the size of tissue replacement surgeries and a rise in healthcare professionals' knowledge of efficient wound treatment are driving the market's expansion.
High costs related to bioactive wound care products to hinder the market growth
The price of receiving medical or healthcare treatment has greatly increased. Costlier chronic wound treatment and wound care management products have had a detrimental impact on their uptake, particularly in developing nations like Asia and RoW. Less pricey items are used in these regions.
Advancements in the technologies in medical treatment to boost the market growth
The introduction of cutting-edge technologies and solutions for treating superficial wounds, such as biomaterials, nanotechnology, and combination dressings, is increasing the total utilization of wound care supplies. These developments provide patients with improved alleviation, acting as high-impact revenue drivers for the sector. In addition to this, small businesses have excellent R&D resources, but often lack the resources to get approvals and introduce items to the market. Large companies with sound financial standing frequently purchase these tiny companies and employ their advanced technologies to create cutting-edge products. All such factors are likely to have numerous opportunities for the growth of the global bioactive wound management market during the forecast period.
Lack of studies on development of bioactive wound care products to pose challenge to the market growth.
Since wound evaluation and care is a complicated procedure including many elements that play a significant influence in the healing process, wound healing is an unmet medical concern in the health sector. Acute wounds, infected wounds, and diabetic wounds are the only uses for conductive biomaterials at this time, which are still in the experimental stage. Next, it is necessary to investigate the specific processes and if conductive biomaterials can aid in the healing of other types of wounds. The manufacturing process is an additional problem. Conducive substance production and incorporation are frequently challenging processes that can call for extreme conditions, which would limit their scope of use and cause environmental problems. Thus, more study is required for the development of bioactive wound products for wound management.
The global bioactive wound management market is divided into product, end-user, and region. Based on the product, the global market is categorized into hydrocolloids dressing, antimicrobial dressing, and alginate dressing. The end-user segment comprises home care settings, long-term patient care, clinics, hospitals, and others.
North America to dominate the global market during the forecast period
Regionally, North America is estimated to dominate the global bioactive wound management market during the forecast period. Wound care products witnessed widespread use in North America, particularly in the United States. This market is well-positioned for growth in this region because of an advanced healthcare system, a good reimbursement system, and higher patient awareness levels. Additionally, the region's high healthcare spending has aided in the continued growth of the healthcare industry. Additionally, the rising usability of injury-related items in the home healthcare market is fostering this sector's expansion. On the other hand, over the projection period, Asia Pacific is predicted to have expansion at a profitable pace. In these developing countries, the target demographic is increasingly made up of people who have diabetic foot, pressure ulcers, and infections.
Major players operating in the global bioactive wound management market include Systagenix Wound Management Ltd., Paul Hartmann AG, Mlnlycke Health Care AB, Smith & Nephew plc., ConvaTec Inc., Derma Sciences, Covalon Technologies Ltd., 3M Healthcare, Covidien plc, and Organogenesis Inc., among others.
By Product
By End User
By Region
FrequentlyAsked Questions
Growing demand for antimicrobial dressings to foster market growth. Further, the market is driven by the rise in the frequency of chronic injuries and the number of surgical operations. Additionally, a spike in the size of tissue replacement surgeries and a rise in healthcare professionals' knowledge of efficient wound treatment are driving the market's expansion.
According to the Zion Market Research report, the global bioactive wound management market was worth about 1.8 (USD billion) in 2021 and is predicted to grow to around 2.9 (USD billion) by 2028, with a compound annual growth rate (CAGR) of around 7.9 percent.
Regionally, North America is estimated to dominate the global bioactive wound management market during the forecast period. Wound care products witnessed widespread use in North America, particularly in the United States. This market is well-positioned for growth in this region because of an advanced healthcare system, a good reimbursement system, and higher patient awareness levels. Additionally, the region's high healthcare spending has aided in the continued growth of the healthcare industry.
Major players operating in the global bioactive wound management market include Systagenix Wound Management Ltd., Paul Hartmann AG, Mlnlycke Health Care AB, Smith & Nephew plc., ConvaTec Inc., Derma Sciences, Covalon Technologies Ltd., 3M Healthcare, Covidien plc, and Organogenesis Inc., among others.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed